Remdesivir improves time to recovery in COVID-19 patients: Study

New York, May 27 () Remdesivir, the antiviral under clinical trials for treatment against novel coronavirus infection, is superior to the standard of care given to COVID-19 patients, according to a new study.
Source: The Economic Times - Category: Consumer Health News Source Type: news